| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Icosavax, Inc. | Director | Common Stock | 627,229 | $9,830,247 | $15.67 | 28 Jul 2021 | By Leslie D. Yamada 2016 Trust |
| Icosavax, Inc. | Director | Common Stock | 124,097 | $1,944,910 | $15.67 | 28 Jul 2021 | Direct |
| Passage BIO, Inc. | Director | Director Stock Option (Right to Buy) | 16,918 | 27 May 2021 | Direct | ||
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 13,871 | 28 May 2021 | Direct | ||
| Phathom Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 12,500 | 21 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924321030501-yamada-tadataka-2021-07-28 | Icosavax, Inc. | 28 Jul 2021 | 0 | $0 | 3 | Director | 28 Jul 2021, 21:23 |
| ATHA | Athira Pharma, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 18:13 |
| PASG | Passage BIO, Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 18:04 |
| PHAT | Phathom Pharmaceuticals, Inc. | 21 May 2021 | 1 | $0 | 4 | Director | 24 May 2021, 17:29 |